EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS
$939,791N01FY2014CANIH
Mayo Clinic Rochester, Rochester MN
Investigators
Abstract
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS
View original record on NIH RePORTER →Mayo Clinic Rochester, Rochester MN
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS
View original record on NIH RePORTER →